Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy.
Daan M van VelzenChantal Maria WiepjesNienke M NotaDaniel H van RaalteRenée de MutsertSuat SimsekMartin den HeijerPublished in: The Journal of clinical endocrinology and metabolism (2022)
Despite studies reporting an increase in insulin resistance in feminizing hormone therapy and a decrease in insulin resistance in masculinizing hormone therapy, the incidence of diabetes in transgender individuals after initiation of hormone therapy was not different compared with the general population.